3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Osteochondroma
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Fibrosis
1
Endometrial Hyperplasia
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Temozolomide
12
Magnetic Resonance Spectroscopy
9
Radiotherapy
6
Surveys and Questionnaires
5
Blood Specimen Collection
4
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Radiation
3
Perfusion Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Lomustine
2
Immunotherapy
2
Drug Therapy
2
Chemoradiotherapy
2
Amplified Fragment Length Polymorphism Analysis
2
regorafenib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadodiamide
1
apatinib
1
Ultrasonography
1
Trail Making Test
1
Therapies, Investigational
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sampling Studies
1
Re-Irradiation
1
Quality of Life
1
Psychometrics
1
Proton Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioblastoma
×
Sampling Studies
×
Clear all
NCT07173829
2025-09-15
BORDEAUX-GLIO
University Hospital, Bordeaux
Not yet recruiting
45 enrolled